comparemela.com

Page 14 - தொடர்பு மேலாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with symptomatic chronic heart failure with reduced ejection fraction (HFrEF), Boehringer Ingelheim and Eli Lilly and Company announced.1

Boehringer Ingelheim: CHMP issues positive opinion for Jardiance (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction

The positive opinion is based on the EMPEROR-Reduced trial, which showed a significant 25 percent reduction in the combined relative risk of cardiovascular death or hospitalization for heart failure

Drolo Project for Drone Use in Lower Airspace

Drolo Project for Drone Use in Lower Airspace 20 May 2021 Unmanned aviation is now really taking off. The electric-powered and locally emission-free flying devices known as drones are coming under the magnifying glass of both companies and researchers. In order to ensure efficient, safe and professional operations, several major challenges need to be addressed. These include, for example, air navigation services for low-level airspace, control of flights when out of visual line of sight, and the possibility of performing several tasks with a single flight. These and many other challenges are being tackled by the Drolo project, which promises to be an undertaking of international significance.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.